Press Releases Atreca, Inc.

Equities

BCEL

US04965G1094

Delayed OTC Markets Other stock markets 01:17:24 2024-04-29 pm EDT			5-day change	1st Jan Change
0.0832 ^USD	+4.00%		-2.12%	-36.97%

Apr. 17	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 10	North American Morning Briefing : Traders Await -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX	Apr. 17	PR
Atreca : Failure to Satisfy Listing Rule - Form 8-K	Mar. 11	PU
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.	Dec. 26	BU
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome	Dec. 26	GL
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives	Nov. 14	GL
Intelligent Bio Solutions Inc. (NASDAQ: INBS): "Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision" (JAGX, BCEL, CDIO)	23-10-13	AQ
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	23-09-21	GL
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	23-09-21	AQ
Atreca : August 2023 Corporate Presentation	23-08-15	PU
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring	23-08-10	GL
Atreca : Corporate Presentation	23-06-20	PU
ATRECA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-15	AQ
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting	23-06-05	GL
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting	23-06-05	AQ
ATRECA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments	23-05-10	GL
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting	23-04-26	GL
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting	23-04-26	AQ
Atreca : Corporate Presentation	23-04-20	PU
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference	23-04-13	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Atreca, Inc.

Equities

BCEL

US04965G1094

Press Releases

Filters